Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-28
2007-08-28
Stockton, Laura L. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S431000, C514S439000, C514S443000
Reexamination Certificate
active
10963979
ABSTRACT:
The present invention relates to benzonaphthoazulene derivatives of tiophene class, to their pharmacologically acceptable salts and solvates, to processes and intermediates for the preparation thereof as well as to their antiinflammatory effects, especially to the inhibition of tumor necrosis factor-α (TNF-α) production and the inhibition of interleukin-1 (IL-1) production as well as to their analgetic action.
REFERENCES:
patent: 3711489 (1973-01-01), Lombardino
patent: 4198421 (1980-04-01), Cherkofsky et al.
patent: 967573 (1975-05-01), None
patent: 20000310 (2002-02-01), None
patent: WO-01/87890 (2001-11-01), None
Fukawa et al., A Method for Evaluating Analgesic Agents in Rats, J. Pharmacol. Meth., 1980, 4:251-259.
Van Assche and Rutgeerts, Anti-TNF agents in Crohn's disease, Exp. Opin. Invest. Drugs, 2000, 9:103-111.
Badger et al., Pharmacological Profile of SB 203580, a Selective Inhibitor of Cytokine Suppressive Binding Protein/p38 Kinase, in Animal Models of Arthritis, Bone Resorption, Endotoxin Shock and Immune Function, J. Pharmac. Env. Therap., 1996, 279(3):1453-1461.
Pfeffer et al., Mice Deficient for the 55kd Tumor Necrosis Factor Receptor Are Resistant to Endotixic Shock, yet Succumb to L. monocytogenes Infection, Cell, 1993, 73:457-467.
Keffer et al., Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis, EMBO J., 1991, 10:4025-4031.
Tsuji et al., Studies on Anti-Inflammatory Agents. VI. Synthesis and Pharmacological Properties of 2,3-Diarylthiophenes, Chem. Pharm. Bull., 1998, 46(2):279-286.
Ueda et al., The Synthesis of 10-(4-Methylpiperazino)dibenzo[b,f]thiepin and Related Compounds. Neurotrpic and Psychotropic Agents, Chem. Pharm. Bull., 1975, 23(10):2223-2231.
Koplcova and Protiva, Synthesis of 7-(4-methylpiperazino)-7,8-dihydrobenzo[b]naphtho[2,1-f]thiepin and of Related Compunds, Collect. Czech. Chem. Commun., 1974, 39:3147-3152.
Georgopoulos et al., Transmembrane TNF Is Sufficient To Induce Localized Tissue Toxicity and Chronic Inflammatory Arthritis in Transgenic Mice, J. Inflamm., 1996, 46:86-97.
Bresnihan, Treatment with Recombinant Human Interleukin-1 Receptor Antagonist (rhIL-1ra) in Rheumatoid Arthritis (RA); Results of a Randomized Double-Blind, Placebo-Controlled Multicenter trial, Arthrit. Rheum., 1996, 39:73.
Mori et al., Attenuation of Collagen-Induced Arthritis in 55-kDa TNF Receptor Type 1 (TNFR1)-IgG1-Treated and TNFR1-Deficient Mice, J. Immunol., 1996, 157:3178-3182.
Elliott et al., Randmoised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis, The Lancet, 1994, 344:1105-1110.
Carswell et al., An endotoxin-induced serum factor that causes necrosis of tumors, Proc. Natl. Acad. Sci. U.S.A., 1975, 72:3666-3670.
Kopicova et al., Potential Tetracyclic Neuroleptics: 12-(4-methylpiperazino)benzo[b]naphtho[2,3-f]theipin and its 12,13-dihydro Derivative, Collect. Czech. Chem. Commun., 1975. 40:1960-1965.
Schweizer et al., Combined automated writhing/motility test for testing analgesics, Agents and Actions, 1988, 23:29-31.
Collier et al., The Abdominal Constriction Response and its Suppression By Analgesic Drugs in the Mouse, Br. J. Pharmac. Chemother., 1968, 32:295-310.
Nyiondi-Bonguen et al., [4+2]—Cycloadditions of 3-Amino-4-imino-4H-thieno[3,4-c][1]benzopyran with some Selected Dienophiles, J. Chem Soc., Perkin Trans. 1, 1994, 15:2191-2195.
Mattioli and Ghia, omega-Dialkylaminoalkyl Ethers of Phenyl-(5-substituted 1-phenyl-1H-pyrazol-4-yl)methanols with Analgesic and Anti-Inflammatory Activity, J. Heterocyclic Chem., 1997, 34:963-968.
Dinarello, Interleukin-1, Rev. Infect Disease, 1984, 6(1):51-95.
Dinarello, An Update on Human Interleukin-1: From Molecular Biology to Clinical Relevance, J. Clinical Immunology, 1985, 5:287-297.
Cagniant and Kirsch, C.R. Acad., Sc., 1976, 283:683-686.
Mercep Mladen
Mesic Milan
Ozimec Ivana
Pesic Dijana
Trojko Rudolf
GlaxoSmith Kline Istrazivocki Centar Zagreb, D.O.O.
Stockton Laura L.
Young J. Scott
LandOfFree
1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3892042